News

2025 marks a milestone year for the EDCTP movement. Discover how Global Health EDCTP3 is strengthening Europe-Africa partnerships, delivering health innovations, mobilising investment, and advancing global health security.

Global Health EDCTP3 will invest up to €147 million in 2026 to support research on TB, LRTIs, HIV and climate-related infectious diseases. Six topics will open for submission in mid-January 2026, with an Info Day on 5 February to support applicants.

Discover how EDCTP-funded research is transforming HIV care in Africa, from breakthroughs in paediatric treatment and meningitis therapy to new Global Health EDCTP3 projects strengthening research capacity and supporting maternal and child health.

EDCTP marks 20 years of Africa–Europe cooperation driving breakthroughs in malaria, sleeping sickness, and worm infections. New child-friendly treatments and all-oral cures highlight the partnership’s impact on global health innovation.

When medicines stop working, lives are at risk. Antimicrobial resistance (AMR) threatens decades of medical progress and demands urgent global action.

Dr Michael Makanga, Executive Director of Global Health EDCTP3, has been awarded a Special Career Achievement Prize of the Prix Galien Africa 2025 in recognition of his exceptional leadership in medical research and his role in amplifying the African voice on the global stage.

When speed meets experience: emergency funding builds on past Mpox research

Global Health EDCTP3 has joined other leading research funders in endorsing the Joint statement on strengthening clinical trials 2025

BioNTech partners with Global Health EDCTP3 to support African research